Total cohort N=225 | |
Female | 216 (96.0) |
Age (years), mean±SD | 64±11.8 |
Ethnicity | |
European | 165 (73.3) |
New Zealand Maori | 36 (16.0) |
Pacific Islanders | 13 (5.8) |
Asian | 11 (4.9) |
Hypertension | 85 (37.8) |
Dyslipidaemia | 64 (28.4) |
Diabetes | 21 (9.3) |
Current smoker | 32 (14.2) |
Stressor on admission | 165 (73.3) |
Type of stressor | |
Emotional | 99 (44) |
Physical | 66 (29) |
None identified | 60 (27) |
Symptoms on admission | |
Chest pain | 181 (80.4) |
Dyspnoea | 63 (28.0) |
Arrhythmia on admission | |
Atrial arrhythmia | 11 (4.9) |
Ventricular arrhythmia | 12 (5.3) |
Pulmonary oedema on chest X-ray | 27 (12.0) |
IABP insertion | 6 (2.7) |
Intubation | 9 (4.0) |
CPAP ventilation | 3 (1.3) |
ST elevation on admission | 68 (30.2) |
LV systolic dysfunction during acute phase | |
Normal/Low normal | 50 (22.2) |
Mild | 61 (27.1) |
Moderate | 80 (34.2) |
Severe | 34 (14.5) |
Normal coronary anatomy | 133 (59.1) |
In-hospital outcomes | |
Death | 4 (1.8) |
Days of hospitalisation, median (IQR) | 4 (3–7) |
Values are n (%) unless otherwise stated.
CPAP, continuous positive airway pressure; IABP, intra-aortic balloon pump; LV, left ventricle.